Merck
MRK
$111.07
Share price
-1.10%
Change (1 day)
20.69%
Change (1 year)
Categories
Merck (MRK) - Net assets
Net assets on the balance sheet as of December 2022 : $46.05 B
According to Merck's latest financial reports the company has $46.05 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Merck - Net assets on balance sheet (from 2001 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $46.05 B | 20.39% |
| 2021-12-31 | $38.25 B | 50.59% |
| 2020-12-31 | $25.40 B | -2.3% |
| 2019-12-31 | $26.00 B | -3.28% |
| 2018-12-31 | $26.88 B | -22.24% |
| 2017-12-31 | $34.56 B | -14.24% |
| 2016-12-31 | $40.30 B | -9.96% |
| 2015-12-31 | $44.76 B | -8.25% |
| 2014-12-31 | $48.79 B | -6.76% |
| 2013-12-31 | $52.32 B | -5.66% |
| 2012-12-31 | $55.46 B | -2.6% |
| 2011-12-31 | $56.94 B | 0.24% |
| 2010-12-31 | $56.80 B | -7.62% |
| 2009-12-31 | $61.49 B | 190.51% |
| 2008-12-31 | $21.16 B | 2.8% |
| 2007-12-31 | $20.59 B | 3.13% |
| 2006-12-31 | $19.96 B | -1.76% |
| 2005-12-31 | $20.32 B | 3.19% |
| 2004-12-31 | $19.69 B | 1.04% |
| 2003-12-31 | $19.49 B | -15.73% |
| 2002-12-31 | $23.12 B | 10.73% |
| 2001-12-31 | $20.88 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $76.80 B | 66.75% | 🇺🇸 USA |
 Novartis NVS | $52.14 B | 13.21% | 🇨🇭 Switzerland |
 Pfizer PFE | $95.91 B | 108.25% | 🇺🇸 USA |
 Abbott Laboratories ABT | $36.90 B | -19.87% | 🇺🇸 USA |
 Eli Lilly LLY | $11.29 B | -75.48% | 🇺🇸 USA |
 Amgen AMGN | $5.34 B | -88.39% | 🇺🇸 USA |
 Sanofi SNY | $80.48 B | 74.75% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $31.88 B | -30.77% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $14.01 B | -69.58% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $8.69 B | -81.13% | 🇮🇱 Israel |